Organización Sanitaria Integrada Ezkerraldea-Enkarterri-Cruces
Organización de Osakidetza
Humanitas University
Rozzano, ItaliaPublications en collaboration avec des chercheurs de Humanitas University (13)
2024
-
Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic
Intensive Care Medicine
-
Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios
Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 32, Núm. 11, pp. 2938-2949
2023
2022
-
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study
Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705
-
Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set
Critical Care, Vol. 26, Núm. 1
-
Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)
Intensive Care Medicine
-
Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set (Critical Care, (2022), 26, 1, (236), 10.1186/s13054-022-04108-8)
Critical Care
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study
Annals of Intensive Care, Vol. 10, Núm. 1
2018
-
Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study
American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403